Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$92.52 - $104.91 $192,164 - $217,898
2,077 New
2,077 $209,000
Q3 2021

Oct 18, 2021

SELL
$81.78 - $95.14 $202,487 - $235,566
-2,476 Closed
0 $0
Q2 2021

Jul 15, 2021

SELL
$85.24 - $94.15 $12,445 - $13,745
-146 Reduced 5.57%
2,476 $226,000
Q1 2021

Apr 12, 2021

BUY
$83.5 - $98.47 $32,398 - $38,206
388 Added 17.37%
2,622 $224,000
Q4 2020

Jan 13, 2021

SELL
$78.07 - $94.43 $37,161 - $44,948
-476 Reduced 17.56%
2,234 $211,000
Q3 2020

Oct 23, 2020

SELL
$82.14 - $91.0 $163,047 - $180,635
-1,985 Reduced 42.28%
2,710 $236,000
Q2 2020

Jul 16, 2020

SELL
$80.93 - $91.1 $2,589 - $2,915
-32 Reduced 0.68%
4,695 $410,000
Q1 2020

Apr 23, 2020

BUY
$70.67 - $99.01 $22,826 - $31,980
323 Added 7.33%
4,727 $390,000
Q4 2019

Feb 05, 2020

BUY
$84.35 - $95.37 $39,728 - $44,919
471 Added 11.98%
4,404 $405,000
Q3 2019

Oct 18, 2019

SELL
$85.54 - $94.26 $1,967 - $2,167
-23 Reduced 0.58%
3,933 $345,000
Q2 2019

Aug 01, 2019

SELL
$75.4 - $92.8 $19,679 - $24,220
-261 Reduced 6.19%
3,956 $361,000
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $317,624 - $363,294
4,217 New
4,217 $404,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.